Primary lymphoma of bone: Extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype

Journal of Clinical Pathology

Volumn 62, Issue 9, 2009, Pages 820-824

  Heyning, F H ^a   Hogendoorn, P C W ^b   Kramer, M H H ^c   Holland, C T Q ^b   Dreef, E ^b   Jansen, P M ^b  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CD30 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; HERMES ANTIGEN; INTERFERON REGULATORY FACTOR 4; METHOTREXATE; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN P53; TENIPOSIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE CANCER; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOMA; MALE; MULTIMODALITY CANCER THERAPY; PAIN; PHENOTYPE; PRIMARY LYMPHOMA OF BONE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOM;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; GERMINAL CENTER; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PHENOTYPE; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 70349125379     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.063156     Document Type: Article

References (20)

1. Desai S, Jambhekar NA, Soman CS, et al. Primary lymphoma of bone: a clinicopathologic study of 25 cases reported over 10 years. J Surg Oncol 1991;46:265-269
2. Heyning FH, Hogendoorn PCW, Kramer MHH, et al. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 1999;13:2094-2098
3. Unni KK, Hogendoorn PCW. Malignant lymphoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002:306-308
4. Berglund M, Thunberg U, Amini RM, et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol 2005;18:1113-1120 (Pubitemid 41224503)
5. Monni O, Franssila K, Joensuu H, et al. BCL2 overexpression in diffuse large B-cell lymphoma. Leuk Lymphoma 1999;34:45-52. (Pubitemid 29248658)
6. Kremmidiotis G, Zola H. Changes in CD44 expression during B cell differentiation in the human tonsil. Cell Immunol 1995;161:147-157
7. Huebner-Chan D, Fernandes B, Yang G, et al. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone. Mod Pathol 2001;14:1000-1007 (Pubitemid 32976788)
8. Martinka M, Comeau T, Foyle A, et al. Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma. Clin Invest Med 1997;20:364-370 (Pubitemid 28052324)
9. Kramer MHH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998;92:3152-3162
10. Kuppers R, Klein U, Hansmann ML, et al. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-1529 (Pubitemid 29526356)
11. de Leval L, Braaten KM, Ancukiewicz M, et al. Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 2003;27:1269-1277 (Pubitemid 37040590)
12. Adams H, Tzankov A, d'Hondt S, et al. Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors. Hum Pathol 2008;39:1323-1330
13. Harris NL. Mature B-cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008:179-267.
14. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282
15. Baar J, Burkes RL, Bell R, et al. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer 1994;73:1194-1199
16. Ostrowski ML, Unni KK, Banks PM, et al. Malignant lymphoma of bone. Cancer 1986;58:2646-2655
17. Beal K, Allen L, Yahalom J. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer 2006;106:2652-2656 (Pubitemid 43911834)
18. Ramadan KM, Shenkier T, Sehn LH, et al. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 2007;18:129-135 (Pubitemid 46152512)
19. Gianelli U, Patriarca C, Moro A, et al. Lymphomas of the bone: a pathological and clinical study of 54 cases. Int J Surg Pathol 2002;10:257-266 (Pubitemid 35461525)
20. Kramer MHH, Hermans J, Parker J, et al. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J Clin Oncol 1996;14:2131-2138 (Pubitemid 26230116)